[go: up one dir, main page]
Skip to main content

Advertisement

SpringerLink
Log in

Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)

  • Research paper
  • Published:
Hormones Aims and scope Submit manuscript

Abstract

OBJECTIVE

To investigate the impact of dietary intervention on Advanced Glycation End products (AGEs) intake on the hormonal and metabolic profile in women with polycystic ovary syndrome (PCOS).

METHODS

After baseline evaluation, 23 women with PCOS [mean±SD, age: 23.4±5.7 years; body mass index (BMI): 26±5.7 kg/m2] underwent the following consecutive 2-month dietary regimens: a hypocaloric diet with ad-libitum AGEs content (Hypo), an isocaloric diet with high AGEs (HA) and an isocaloric diet with low AGEs (LA). Metabolic, hormonal and oxidative stress status was assessed and AGEs levels were determined in all subjects after the completion of each dietary intervention.

RESULTS

Serum levels of AGEs, testosterone, oxidative stress, insulin and HOMA-IR index were significantly increased on the HA compared to the Hypo diet and subsequently decreased on the LA diet (compared to HA) (p<0.05 for all parameters). BMI remained unaltered throughout the HA and LA periods compared to the Hypo period. Serum AGEs were strongly correlated with insulin, as well as with HOMA, during the LA dietary period (r = 0.53, p = 0.02 and r=0.51, p = 0.03, respectively). For the same period, dietary AGEs were correlated with insulin levels (rho = 0.49, p = 0.04).

CONCLUSIONS

Modifications of dietary AGEs intake are associated with parallel changes in serum AGEs, metabolic, hormonal and oxidative stress biomarkers in women with PCOS. These novel findings support recommendations for a low AGEs dietary content along with lifestyle changes in women with PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al, 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84: 4006–4011.

    Article  CAS  PubMed  Google Scholar 

  2. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC, 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20: 535–582.

    Article  CAS  PubMed  Google Scholar 

  3. Brownlee M, Vlassara H, Cerami A, 1984 Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101: 527–537.

    Article  CAS  PubMed  Google Scholar 

  4. Vlassara H, Cai W, Crandall J, et al, 2002 Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci USA 99: 15596–15601.

    Article  CAS  PubMed  Google Scholar 

  5. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H, 2005 Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci 1043: 461–466.

    Article  CAS  PubMed  Google Scholar 

  6. Ahmed N, 2005 Advanced glycation end products-role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3–21.

    Article  CAS  PubMed  Google Scholar 

  7. Ahmed N, Thornalley PJ, 2003 Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 31: 1417–1422.

    Article  CAS  PubMed  Google Scholar 

  8. Diamanti-Kandarakis E, Katsikis I, Piperi C, et al, 2008 Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 69: 634–641.

    Article  CAS  Google Scholar 

  9. Diamanti-Kandarakis E, Piperi C, Kalofoutis A, Creatsas G, 2005 Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 62: 37–43.

    Article  CAS  Google Scholar 

  10. Diamanti-Kandarakis E, Piouka A, Livadas S, et al, 2009 Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome. Eur J Endocrinol 160: 847–853.

    Article  CAS  PubMed  Google Scholar 

  11. Diamanti-Kandarakis E, Piperi C, Patsouris E, 2007 Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries. Histochem Cell Biol 127: 581–589.

    Article  CAS  PubMed  Google Scholar 

  12. Ames JM, 2008 Determination of N epsilon-(carboxymethyl) lysine in foods and related systems. Ann NY Acad Sci 1126: 20–24.

    Article  CAS  PubMed  Google Scholar 

  13. Uribarri J, Cai W, Peppa, M, et al, 2007 Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 62: 427–433.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Uribarri J, Stirban A, Sander D, et al, 2007 Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care 30: 2579–2582.

    Article  CAS  PubMed  Google Scholar 

  15. Koschinsky T, He CJ, Mitsuhashi T, et al, 1997 Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci USA 94: 6474–6479.

    Article  CAS  PubMed  Google Scholar 

  16. Sebekova K, Krajcoviova-Kudlackova M, Schinzel R, Faist V, Klvanová J, Heidland A, 2001 Plasma levels of advanced glycation end products in healthy, long-term vegetarians and subjects on a western mixed diet. Eur J Nutr 40: 275–281.

    Article  CAS  PubMed  Google Scholar 

  17. Uribarri J, Peppa M, Cai, W, et al, 2003 Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients. Am J Kidney Dis 42: 532–538.

    Article  CAS  PubMed  Google Scholar 

  18. Negrean M, Stirban A, Stratmann, B, et al, 2007 Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 85: 1236–1243.

    Article  CAS  PubMed  Google Scholar 

  19. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al, 2009 Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30: 293–342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Diamanti-Kandarakis E, Piperi C, Alexandraki K, et al, 2006 Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome. Metabolism 55: 494–500.

    Article  CAS  PubMed  Google Scholar 

  21. Diamanti-Kandarakis E, Piperi C, Alexandraki KI, et al, 2009 The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women. Minerva Endocrinol 34: 97–104.

    PubMed  CAS  Google Scholar 

  22. Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, et al, 2007 Accumulation of dietary glycotoxins in the reproductive system of normal female rats. J Mol Med (Berl) 85: 1413–1420.

    Article  CAS  Google Scholar 

  23. Zawadzki JK, Dunaif A 1990 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Blackwell Scientific Publications, Boston; pp, 377–384.

    Google Scholar 

  24. Mitsuhashi T, Vlassara H, Founds HW, Li YM, 1997 Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Methods 207: 79–88.

    Article  CAS  PubMed  Google Scholar 

  25. Sheetz MJ, King GL, 2002 Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288: 2579–2588.

    Article  CAS  PubMed  Google Scholar 

  26. Lin L, Park S, Lakatta EG, 2009 RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403–1413.

    Article  CAS  PubMed Central  Google Scholar 

  27. Makita Z, Radoff S, Rayfield EJ, et al, 1991 Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836–842.

    Article  CAS  PubMed  Google Scholar 

  28. Ono Y, Aoki S, Ohnishi K, et al, 1998 Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications. Diabetes Care 21: 1027.

    Article  CAS  PubMed  Google Scholar 

  29. Busch M, Franke S, Ruster C, Wolf G, 2010 Advanced glycation end-products and the kidney. Eur J Clin Invest 40: 742–755.

    Article  CAS  PubMed  Google Scholar 

  30. Forster A, Kuhne Y, Henle T, 2005 Studies on absorption and elimination of dietary maillard reaction products. Ann NY Acad Sci 1043: 474–481.

    Article  CAS  PubMed  Google Scholar 

  31. Geissler S, Hellwig M, Zwarg M, Markwardt F, Henle T, Brandsch M, 2010 Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1. J Agric Food Chem 58: 2543–2547.

    Article  CAS  PubMed  Google Scholar 

  32. Hofmann SM, Dong HJ, Li Z, et al, 2002 Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51: 2082–2089.

    Article  CAS  PubMed  Google Scholar 

  33. Peppa M, Brem H, Ehrlich P, et al, 2003 Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52: 2805–2813.

    Article  CAS  PubMed  Google Scholar 

  34. Peppa M, Uribarri J, Vlassara H, 2004 The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep 4: 31–36.

    Article  PubMed  Google Scholar 

  35. Stirban A, Negrean M, Gotting C, et al, 2008 Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokines. Ann N Y Acad Sci 1126: 276–279.

    Article  CAS  PubMed  Google Scholar 

  36. Altieri P, Cavazza C, Pasqui F, Morselli AM, Gambieri A, Pasquali R, 2013 Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome. Clin Endocr 78: 52–59.

    Article  CAS  PubMed  Google Scholar 

  37. Cassese A, Esposito I, Fiory F, et al, 2008 In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. J Biol Chem 283: 36088–36099.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lo MC, Lu CI, Chen MH, et al, 2010 Glycoxidative stress-induced mitophagy modulates mitochondrial fates. Ann N Y Acad Sci 1201: 1–7.

    Article  CAS  PubMed  Google Scholar 

  39. Otani H 2011 Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome. Antioxid Redox Signal 15: 1911–1926.

    Article  CAS  PubMed  Google Scholar 

  40. Sabuncu T, Vural H, Harma M, Harma M, 2001 Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 34: 407–413.

    Article  CAS  PubMed  Google Scholar 

  41. Gonzalez F, Rote NS, Minium J, Kirwan JP, 2006 Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91: 336–340.

    Article  CAS  PubMed  Google Scholar 

  42. Uribarri J, Woodruff S, Goodman S, et al, 2010 Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110: 911–916.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Pouillart P, Mauprivez H, Ait-Ameur L, et al, 2008 Strategy for the study of the health impact of dietary Maillard products in clinical studies: the example of the ICARE clinical study on healthy adults. Ann N Y Acad Sci 1126: 173–176.

    Article  CAS  PubMed  Google Scholar 

  44. Senn SS 2002, Cross-over Trials in Clinical Research. John Wiley and Son, Chichester 2002.

    Book  Google Scholar 

  45. Pignone MP, Ammerman A, Fernandez L, et al, 2003 Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive services Task Force. Am J Prev Med 24: 75–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Unit, Third Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece

    Evangelia Tantalaki, Sarantis Livadas, Anastasios Kollias, Aikaterini Koulouri, Charikleia Christakou & Evanthia Diamanti-Kandarakis MD, Phd

  2. Department of Biological Chemistry, University of Athens Medical School, Athens, Greece

    Christina Piperi & Christos Adamopoulos

Authors
  1. Evangelia Tantalaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina Piperi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarantis Livadas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anastasios Kollias
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christos Adamopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aikaterini Koulouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Charikleia Christakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Evanthia Diamanti-Kandarakis MD, Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evanthia Diamanti-Kandarakis MD, Phd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tantalaki, E., Piperi, C., Livadas, S. et al. Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS). Hormones 13, 65–73 (2014). https://doi.org/10.1007/BF03401321

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401321

Key words

Search

Navigation